These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8566257)
21. The use of vaginal ultrasound for monitoring endometrial preparation in a donor oocyte program. Shapiro H; Cowell C; Casper RF Fertil Steril; 1993 May; 59(5):1055-8. PubMed ID: 8486173 [TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol. Scott RT; Ross B; Anderson C; Archer DF Obstet Gynecol; 1991 May; 77(5):758-64. PubMed ID: 2014092 [TBL] [Abstract][Full Text] [Related]
25. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure. Steingold KA; Matt DW; DeZiegler D; Sealey JE; Fratkin M; Reznikov S J Clin Endocrinol Metab; 1991 Aug; 73(2):275-80. PubMed ID: 1906893 [TBL] [Abstract][Full Text] [Related]
26. Peripheral progesterone (P) levels and endometrial response to various dosages of vaginally administered P in estrogen-primed women. Pasquale SA; Foldesy RG; Levine JP; Bachmann GA; Blackwell RE Fertil Steril; 1997 Nov; 68(5):810-5. PubMed ID: 9389807 [TBL] [Abstract][Full Text] [Related]
27. [A "no-bleeding" substitute hormone treatment with an oral microdose progesterone. A prospective multicenter study]. Gillet JY; Faguer B; André G; Magnin G; de Lignières B; Philippe E J Gynecol Obstet Biol Reprod (Paris); 1994; 23(4):407-12. PubMed ID: 8051369 [TBL] [Abstract][Full Text] [Related]
28. [The endometrium under the effects of hormone replacement therapy in menopause with percutaneous estradiol and low-dose micronized progesterone]. Philippe E; Faguer B; Engelman A; Charpin C; Loubière R; de Mascarel A; Leduc F; Dupin P; Hemet J; Vauzelle JL Pathologica; 1993; 85(1099):475-87. PubMed ID: 8127629 [TBL] [Abstract][Full Text] [Related]
29. Comparison of steady state development and reduction of menopausal symptoms after oral or transdermal delivery of 17-β-estradiol in young healthy symptomatic menopausal women. Rohr UD; Volko CD; Schindler AE Horm Mol Biol Clin Investig; 2014 Jun; 18(3):123-36. PubMed ID: 25390008 [TBL] [Abstract][Full Text] [Related]
30. Transdermal estrogen replacement in ovarian failure for ovum donation. Droesch K; Navot D; Scott R; Kreiner D; Liu HC; Rosenwaks Z Fertil Steril; 1988 Dec; 50(6):931-4. PubMed ID: 3203756 [TBL] [Abstract][Full Text] [Related]
34. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy. Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Axiotis C; Loriaux DL; Nieman LK Am J Obstet Gynecol; 1992 Jul; 167(1):60-5. PubMed ID: 1442957 [TBL] [Abstract][Full Text] [Related]
35. Clomiphene citrate affects cervical mucus and endometrial morphology independently of the changes in plasma hormonal levels induced by multiple follicular recruitment. Massai MR; de Ziegler D; Lesobre V; Bergeron C; Frydman R; Bouchard P Fertil Steril; 1993 Jun; 59(6):1179-86. PubMed ID: 8495762 [TBL] [Abstract][Full Text] [Related]
36. Effects of the route of estrogen administration and exercise on hormonal levels in postmenopausal women. Williams CD; Dobridge JD; Meyer WR; Hackney AC Fertil Steril; 2002 Jun; 77(6):1118-24. PubMed ID: 12057715 [TBL] [Abstract][Full Text] [Related]
37. Experience with a 'physiological' steroid replacement regimen for the establishment of a receptive endometrium in women with premature ovarian failure. Critchley HO; Buckley CH; Anderson DC Br J Obstet Gynaecol; 1990 Sep; 97(9):804-10. PubMed ID: 2242365 [TBL] [Abstract][Full Text] [Related]
38. Polysiloxane vaginal rings and cylinders for physiologic endometrial priming in functionally agonadal women. Simon JA; Rodi IA; Stumpf PG; Sauer MV; Cohen SW; Ford LC; Bustillo M; Buster JE Fertil Steril; 1986 Oct; 46(4):619-25. PubMed ID: 3758383 [TBL] [Abstract][Full Text] [Related]
39. Potential enhancement of endometrial receptivity in cycles using controlled ovarian hyperstimulation with antiprogestins: a hypothesis. Paulson RJ; Sauer MV; Lobo RA Fertil Steril; 1997 Feb; 67(2):321-5. PubMed ID: 9022610 [TBL] [Abstract][Full Text] [Related]
40. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone. Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]